Therapeutic Repurposing of Antidiabetic Drugs in Diabetes-associated Comorbidities
- 1 March 2024
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Drug Therapy
- Vol. 19 (2) , 178-194
Abstract
Background: Diabetic patients suffer from various comorbidities like cardiovascular diseases (CVDs), cancer, obesity, cognitive impairment, gout, leishmaniasis, etc. Objective: We aimed to review the pathological links between diabetes and its comorbidities and discuss the justification for using antidiabetic drugs in diabetes and associated comorbidities. Methods: Diabetic patients accompanied by comorbidities had to undergo a multidrug regimen apart from their common antidiabetic drugs, which affects their quality of life. There have been reports that some antidiabetic drugs ameliorate the comorbidities associated with diabetes. For instance, metformin is implicated in CVDs, cancer, as well as in cognitive impairment like Alzheimer's disease (AD); glyburide, a sulfonylurea, is found to be effective against leishmaniasis; and voglibose, an α- glucosidase inhibitor, is found to have suitable binding property against SARS-CoV-2 infection in diabetic patients. Targeting the comorbidities of diabetes with antidiabetic drugs may reduce the load of multidrug therapy in diabetic patients. Results: The effectiveness of antidiabetic drugs against some diabetic comorbidities between the two pathophysiological conditions, i.e., diabetes and its comorbidities, may be due to certain bidirectional links like inflammation, oxidative stress, disruption in the metabolic milieu and obesity. There are published reports of the repurposing of antidiabetic drugs for specific diseases, however, compiled repurposed reports of antidiabetic drugs for a wide range of diseases are scarce. Conclusion: In this review, we attempt to justify the use of antidiabetic drugs in diabetes and associated comorbidities.Keywords
Funding Information
- All India Council for Technical Education (8-112/RIFD/RPS/NER/Policy/1/2018-19)
- Indian Council of Medical Research (45/10/2018/TM/BMS)
This publication has 151 references indexed in Scilit:
- Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical EvidenceCNS Drugs, 2013
- Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231BMC Pharmacology and Toxicology, 2013
- Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effectsPhysiology & Behavior, 2012
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on MetforminThe Journal of Clinical Endocrinology & Metabolism, 2012
- Cellular and molecular mechanisms of metformin: an overviewClinical Science, 2011
- Role of resistin in cardiac contractility and hypertrophyJournal of Molecular and Cellular Cardiology, 2008
- AcromegalyEndocrinology and Metabolism Clinics of North America, 2008
- Long term pharmacotherapy for obesity and overweight: updated meta-analysisBMJ, 2007
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- Neuropeptide Y in normal eating and in genetic and dietary-induced obesityPhilosophical Transactions of the Royal Society B: Biological Sciences, 2006